Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul;20(7):650-2.
doi: 10.1111/j.1525-1497.2005.0118.x.

Brief report: risk factors for pneumococcal vaccine refusal in adults: a casecontrol study

Affiliations

Brief report: risk factors for pneumococcal vaccine refusal in adults: a casecontrol study

Lesley S Miller et al. J Gen Intern Med. 2005 Jul.

Abstract

Background: Invasive pneumococcal disease is a significant cause of morbidity and mortality in the United States. Despite availability of an effective vaccine, many patients refuse vaccination.

Objective: To investigate patient characteristics and features of the patient-provider relationship associated with pneumococcal vaccine refusal.

Design: Case-control study using chart review.

Patients: Five hundred adults from the medical clinics of a 1,000-bed inner-city teaching hospital.

Measurements and main results: Independent risk factors for pneumococcal vaccine refusal included patient-provider gender discordance (odds ratio (OR)=2.09, 95% confidence interval (CI) 1.07 to 4.09); a visit to a not-usual provider at the time of vaccine offering (OR=2.26, 95% CI 1.13 to 4.49); never having received influenza vaccination (OR=7.44, 95% CI 3.76 to 14.76); prior pneumococcal vaccine refusals (OR=3.45, 95% CI 1.60 to 7.43); and a history of ever having refused health maintenance tests (OR=2.86, 95% CI 1.40 to 5.84).

Conclusions: We have identified both patient factors and factors related to the patient-provider relationship that are risk factors for pneumococcal vaccine refusal. By identifying patients at risk for pneumococcal vaccine refusal, efforts to increase vaccination rates can be better targeted.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–1746. - PubMed
    1. Shevlin JD, Summers-Bean C, Thomas D, Whitney CG, Todd D, Ray SM. A systematic approach for increasing pneumococcal vaccination at an inner-city public hospital. Am J Prev Med. 2002;22:92–97. - PubMed
    1. United States Department of Health and Human Services. Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health. 2nd edn. 2 Vols. Washington, DC: U.S. Department of Health and Human Services; 2000.
    1. Centers for Disease Control and Prevention. Influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years—United States, 2002. MMWR. 2003;52:987–992. - PubMed
    1. Bovier PA, Chamot E, Gallacchi MB, Loutan L. Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunization in Swiss adults. Vaccine. 2001;19:4760–4767. - PubMed

Publication types

Substances